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Abstract:    The structure of four synthesized thiosemicarbazones, 
substituted or not, of benzophenone has been confirmed by spectrometrical 
analysis IR, NMR 
1H and 
13C. Their anti-trypanosomal activities were 
evaluated on Trypanosoma brucei brucei. Among these compounds, 
benzophenone 4-phenyl-3-thiosemicarbazone 4 has the highest activity with 
the half-inhibitory concentration (IC50) = 8.48 micromolar (µM). 
Benzophenone 4-methyl-3-thiosemicarbazone 3 and benzophenone 
thiosemicarbazone 1 showed moderate anti-trypanosomal activity with IC50 
values equal to 23.27 µM and 67.17 µM respectively. Benzophenone 
2-methyl-3-thiosemicarbazone  2 showed no activity up to IC50 = 371.74 
µM. 
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INTRODUCTION 
 
Trypanosomes are pathogens of Chagas disease in Central and South America and 
sleeping sickness in sub-Saharan Africa [1]. In Africa, the protozoan parasite of the 
genus Trypanosoma causes animal (AAT) and human African trypanosomiasis (HAT) 
[2]. They are transmitted by tsetse flies (tsetse fly): Glossina palpalis palpalis and 
Glossina morsitans morsitans vectors of Trypanosoma brucei gambiense and 
Trypanosoma brucei rhodesiense respectively. Trypanosoma brucei brucei, responsible 
of animal trypanosomiasis,  can be transmitted both by the palpalis group and the 
morsitans group [3]. This type of trypanosome is studied in recent years across Africa 
(example of Cameroon and Ivory Coast) [4, 5].  These diseases are responsible for 
considerable mortality and economic losses, and until now the drugs commonly used 
have often been very toxic and expensive, with no vaccine available [2]. They are lethal 
if not treated [6]. Therefore, the development of new drugs in the treatment of these 
diseases is necessary and imperative [1]. 
The thiosemicarbazones, biologically active molecules, are known in the fight against 
microbial and parasitic diseases. Through to their multiple pharmacological properties: 
antiviral [7, 8], antibacterial [9, 10], antiparasitic [11 – 13], antitumor [14 – 16], 
anticonvulsant [17, 18], they are agents that block the development of microbes and 
parasites. Moreover, these properties are accentuated when these molecules are 
N(4)-substituted [19]. The presence of sulfur atom, which cheeks a key role in the 
antimicrobial activity generally provides a higher activity compared to semicarbazones 
[20, 21]. Recent studies have shown that thiosemicarbazones exhibit inhibitory effects 
on parasite including Trypanosoma brucei and Plasmodium falciparum [12, 22 – 24]. 
The aim of this work is to synthesize benzophenone thiosemicarbazones substituted or 
not and to evaluate their anti-trypanosomal activity on Trypanosoma brucei brucei.  
 
 
MATERIALS AND METHODS 
 
Materials  
 
Equipment 
The melting points were taken on a fusionometer of the type electrothermal 1A 9000 
and have not been corrected. The IR spectra were recorded on a Perkin-Elmer FTIR 
286. The frequencies of absorption bands are expressed in cm
-1. The NMR spectra were 
recorded on a Brucker 500 in DMSO-d6 or CDCl3 and the frequencies for 
1H and 
13C 
are 300 – 400 MHz and 100 MHz respectively. Chemical shifts are given in parts per 
million (ppm) relative to tetramethylsilane as a benchmark. 
 
Reagents  
Four thiosemicarbazides: thiosemicarbazide, 2-methyl-3-thiosemicarbazide, 4-methyl-3-
thiosemicarbazide and 4-phenyl-3-thiosemicarbazide obtained from 
AALDRICH
R 
(SIGMA-ALDRICH Chemie GmbH, Germany) were used on benzophenone purchased 
from PROLABO (EMB de 45-Briare, France). 
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General protocol for the preparation of thiosemicarbazones of benzophenone 
We prepared an equimolar mixture (0.001 mol) of benzophenone dissolved in 1.5 mL of 
ethyl alcohol 95° and thiosemicarbazide dissolved in 1 mL of 1N hydrochloric acid. The 
mixture is stirred until the appearance of precipitate. We leave the bustle continue 30 
minutes to 1 hour depending on the reagent to complete the reaction. The precipitate is 
filtered, washed with cold distilled water until neutrality, dried and then recrystallized in 
ethanol 95°. 
 
Pharmacology 
 
Biological material 
The material used for the study of pharmacological properties consists of trypanosomes: 
Trypanosoma brucei brucei (Tbb) according to the protocol below. Anti-trypanosomal 
activity is assessed on the half-inhibitory concentrations IC50 expressed in micromolar 
(µM) to allow comparison with the literature [11, 13]. 
 
Anti-trypanosomal activity (LILIT, Alamar Blue
TM) 
The test is performed on the bloodstream form of the strain 427 of Trypanosoma brucei 
brucei by the «LILIT Alamar Blue
TM» method [25 – 27]. The stock solutions of 
thiosemicarbazones have been prepared from an initial concentration of 10 mg·mL
-1 in 
DMSO. The trypanosomes are grown in a medium containing 10% of heat-inactivated 
fetal calf serum and bloodstream form supporting factor. The trypanosome suspensions 
were adjusted to 5·10
-4 tryp·mL
-1. In each well, 50 μL of different dilutions of the stock 
solution were added to 50 μL of suspension of trypanosomes. The plates were then 
incubated at 37 °C for 72 hours in an atmosphere with 5% CO2. 10 μL of dye "Alamar 
Blue
TM" is added to each well and then incubated for 4 hours. The dye "Alamar Blue
TM" 
is a reagent for detecting enzymatic activity. The wells in which the concentration of 
compound is insufficient to inhibit the proliferation of trypanosomes are stained. The 
CMI is the concentration of unstained wells in which there is the lowest amount of 
thiosemicarbazone. The plate reading is made in comparison with control wells on a 
fluorescence plate reader using an excitation wavelength of 530 nm and an emission 
wavelength 590 nm. 
 
 
RESULTS AND DISCUSSION 
 
Chemistry 
 
Four thiosemicarbazones (substituted or not) of benzophenone were synthesized by 
condensation reaction with thiosemicarbazides. Their formulas are given in Figure 1. 
The steric and electronic effects of various substituents of thiosemicarbazides could 
explain the difference in yield reactions with benzophenone. The 4-phenyl-3-
thiosemicarbazide is more reactive, it forms bright yellow crystals. The product 1 is 
obtained at 50 minutes with 84% (yield) higher performance to 25% (yield) in 30 hours 
shown in the work of Tarlok et al. in 2006 [28]. The physicochemical data are presented 
in Table 1. GLINMA, GBAGUIDI, KPOVIESSI, FATONDJI, POUPAERT and ACCROMBESSI 
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Figure 1. Structures of thiosemicarbazones synthesized 
 
               Table 1.  Physicochemical properties of thiosemicarbazones of benzophenone  
Compound  Raw 
formulae 
Molecular weight  
[g·mol
-1] 
Melting point 
[°C] 
Yield  
[%] 
1  C14H13N3S  255 168  84 
2  C15H15N3S  269 179  61 
3  C15H15N3S  269 164  52 
4  C20H17N3S  331 153  82 
 
The structure of these compounds is confirmed by their IR, 
1H and 
13C NMR. 
Spectrometrical data are recorded in Tables 2 – 4. 
 
IR spectra  
The analysis of the spectra led to vibration frequencies summarized in Table 2.  
The terminal NH2 group of compounds 1 and 2 shows three different frequencies of 
vibration with two NH (3410; 3248 and 3426; 3292 cm
-1 respectively for 1 and 2), 
which have different chemical environment, and a frequency NH2 (3151 and 3121 cm
-1 
for  1 and 2). Compounds 3 and 4 N(4)-substituted did not show the frequency of 
vibration NH2 corresponding to this function. Except the product 2, compound N(2)-
substituted, the others show a vibration frequency HN(2) (respectively to 3346; 3315 
and 3304 cm
-1 for 1,  3 and 4). For each of the spectra we find three types of vibrations 
of thioamide group (N-CS-N) [28] (Table 2). 
 
1H NMR spectra  
The spectral data, chemical shifts of proton peaks in the structure, of compounds are 
shown in Table 3.  
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Table 2. Frequencies of vibration in IR 
Frequencies of vibration in cm
-1  Functions 
1   2 3  4  
NH  3410; 3346; 3248  3426; 3292  3439; 3315  3338; 3304 
NH2 3151  3121  -  - 
C=N 1608  1574 1531 1594 
(N-CS-N)  1069; 1026; 846  1074; 1030; 884  1073; 1024; 823  1071; 1031; 855 
 
Table 3. Chemical shifts of protons in 
1H RMN 
Proton chemical shifts in ppm  Functions 
1   2 3  4  
H N(4)H  6.42 (s, 2H)  Broad peak from 
6.1 to 7.1 (s, 2H)  7.70 (s, 1H)  9.45 (s, 1H) 
H N(2)H  8.60 (s, 1H)  -  8.65 (s, 1H)  8.75 (s, 1H) 
H 
Aromatic 
From 7.20 to 
7.60 (m, 10H) 
From 7.25 
to7.60 (m, 10H) 
From 7.25 to 
7.55 (m, 10H) 
From 7.25 to 
7.60 (m, 15H) 
CH3 (N-CH3) -  3.15 N(2)        
(s, 3H) 
3.25 N(4)        
(s, 3H)  - 
s: singlet, m: multiplet 
 
The proton HN(2) of thiosemicarbazone 1 and 4-methyl-3-thiosemicarbazone 3 has a 
high chemical shift (8.60 and 8.65 ppm for 1 and 3 respectively) due to the effect of 
electron with drawing groups C=S and C=N. Regarding the 4-phenyl-3-
thiosemicarbazone 4, the proton HN(4) connected to the phenyl group has its chemical 
shift even higher (9.45 ppm). This value is due to the phenyl group that is relocating the 
free pair of nitrogen and the effect of the current cycle (diamagnetic anisotropy) both of 
which deplete their environment by moving downfield (Table 3). 
  
13C NMR spectra  
The chemical shifts corresponding to different types of carbons (peaks) present in each 
of the structures of compounds are given in Table 4. 
 
Table 4. Chemical shifts of carbon in 
13C RMN 
Carbon chemical shifts in ppm  Functions 
1
   2 3  4  
C=S  179.05 181.78 178.67 175.15 
C=N 150.21  15.27  149.57  149.22 
N-CH3  -  41.62 N(2)  31.27 N(4)  - 
Cα  136.50 137.41 136.79 135.73 
Cβ  128.54 129.30 128.56 129.15 
Cγ  127.88 128.39 127.72 128.02 
Cδ  131.16 134.97 131.46 130.49 
Cα’ -  -  -  137.11 
Cβ’ -  -  -  127.75 
Cγ’ -  -  -  129.65 
Cδ’ -  -  -  125.38 GLINMA, GBAGUIDI, KPOVIESSI, FATONDJI, POUPAERT and ACCROMBESSI 
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The analysis of these results confirms the presence of functions C=S, C=N, aromatic 
carbons and methyl carbons substituted even in products 2 and 4 (Table 4). 
 
Pharmacology 
 
Our compounds were tested for their anti-trypanosomal activity on Trypanosoma brucei 
brucei. Their IC50 values are shown in Table 5. In decreasing order of activity it is the 
compound 4 (8.48 µM), 3 (23.27 µM), 1 (67.17 µM) and 2 (371.74 µM). 
The works of Fujii et al. [11] and Du et al. [13] showed that the thiosemicarbazones are 
trypanocidal when their IC50 values are lower than 10 µM, and are regarded as moderate 
anti-trypanosomal agents if these values are between 10 and 100 µM, and have little or 
no activity when their IC50 are higher than 100 µM. This work allows us to classify the 
compound 4 as trypanocidal, compounds 3 and 1 as moderate anti-trypanosomal agents 
and compound 2 as having little or no activity on Trypanosoma brucei brucei (Table 5). 
 
Table 5. Anti-trypanosomal activities of benzophenone thiosemicarbazones 
Compound IC50 [µM]  Anti-trypanosomal activity 
1  67.17 moderate 
2  no effect up to 371.74  little or no 
3  23.27 moderate 
4  8.48 trypanocidal 
 
It is well known that in most cases, N(4)-alkyl or N(4)-aryl thiosemicarbazones exhibit 
greater anti-trypanosomal activity than their corresponding unsubstituted, probably due 
to increased lipophilicity [1, 29]. This is confirmed by our results.  
In our case, compound 3 is N(4)-methyl and the compound 4 is N(4)-phenyl 
thiosemicarbazone with greater activity for 4 (Table 5). Compound 1,  not                
N(4)-substituted, although active, is more moderated. The compound 2,  though        
N(2)-substituted, has a little or no effect. The substitution at position N(2) appears to 
decrease the activity. The literature gives no indication on the anti-trypanosomal 
activities of our different compounds. 
 
 
CONCLUSIONS 
 
In total, four thiosemicarbazones have been synthesized, such as: benzophenone 
thiosemicarbazone  1, benzophenone 2-methyl-3-thiosemicarbazone  2, benzophenone 
4-methyl-3-thiosemicarbazone  3 and benzophenone 4-phenyl-3-thiosemicarbazone 4. 
The yield of product 1 was significantly improved compared to the work of Tarlok et al. 
[28]. The structures were confirmed by spectrometrical analysis IR, 
1H and 
13C NMR. 
The evaluation of pest control activities of these compounds on Trypanosoma brucei 
brucei, not yet investigated to our knowledge, reveals that the compound shown anti-
trypanosomal activity. Such molecules could open a promising avenue in the fighting 
against trypanosomiasis.  
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